comparemela.com

Izanne Roos News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Rituximab Not Noninferior to Ocrelizumab for Relapsing-Remitting MS

For patients with relapsing-remitting multiple sclerosis (MS), rituximab is not noninferior to ocrelizumab.

Rituximab Not Noninferior to Ocrelizumab for Relapsing-Remitting MS

For patients with relapsing-remitting multiple sclerosis (MS), rituximab is not noninferior to ocrelizumab.

Rituximab Not Noninferior to Ocrelizumab for Relapsing-Remitting MS

WEDNESDAY, June 14, 2023 (HealthDay News) For patients with relapsing-remitting multiple sclerosis (MS), rituximab is not noninferior to ocrelizumab, according to a study published online June 12 in JAMA

Rituximab not noninferior to ocrelizumab for relapsing-remitting multiple sclerosis

Rituximab not noninferior to ocrelizumab for relapsing-remitting multiple sclerosis
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.